Publicaciones en las que colabora con ELIANA BARRIOCANAL CASADO (12)

2022

  1. The Q-junction and the inflammatory response are critical pathological and therapeutic factors in CoQ deficiency

    Redox Biology, Vol. 55

2021

  1. Animal models of coenzyme q deficiency: Mechanistic and translational learnings

    Antioxidants, Vol. 10, Núm. 11

  2. Metabolic targets of coenzyme q10 in mitochondria

    Antioxidants, Vol. 10, Núm. 4

  3. β-RA Targets Mitochondrial Metabolism and Adipogenesis, Leading to Therapeutic Benefits against CoQ Deficiency and Age-Related Overweight

    Biomedicines, Vol. 9, Núm. 10

2020

  1. Coenzyme Q10 modulates sulfide metabolism and links the mitochondrial respiratory chain to pathways associated to one carbon metabolism

    Human Molecular Genetics, Vol. 29, Núm. 19, pp. 3296-3311

2019

  1. β-RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in Coq9 R239X mice

    EMBO Molecular Medicine, Vol. 11, Núm. 1

  2. Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease

    EBioMedicine, Vol. 42, pp. 511-523

  3. The paradox of coenzyme Q10 in aging

    Nutrients, Vol. 11, Núm. 9

2018

  1. Reduction in the levels of CoQ biosynthetic proteins is related to an increase in lifespan without evidence of hepatic mitohormesis

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome

    EMBO Molecular Medicine, Vol. 9, Núm. 1, pp. 78-95

  2. Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases

    PLoS ONE, Vol. 12, Núm. 8

2016

  1. Gene therapy corrects mitochondrial dysfunction in hematopoietic progenitor cells and fibroblasts from Coq9R239X mice

    PLoS ONE, Vol. 11, Núm. 6